背景:维生素A(VA)缺乏和过量对发育产生负面影响,增长,骨骼健康。世界卫生组织对VA缺乏引起的干眼症的护理标准,是三种50,000-200,000IU的高剂量VA补充剂,根据年龄,这可能会导致某些个体的维生素A过多症。
目的:本研究在两个仔猪研究中测量了三个VA剂量后的VA状态。
方法:在研究1中,将五组仔猪(n=10/组)在出生后10d断奶,并在第0、1和7天口服0;25,000;50,000;100,000;或200,000IUVA酯。在第14-15天,对仔猪进行了VA缺乏的改良相对剂量反应(MRDR)测试,被杀了.收集组织用于HPLC分析。研究2在三组(n=13/组)中使用相同的设计,在16d断奶并施用0;25,000;和200,000IU剂量。
结果:在研究1(最终体重:3.6+0.7公斤)中,在50,000;100,000;和200,000IU组中的40,90和100%中,肝脏VA浓度为维生素缺乏症.25,000IU组100%足够,安慰剂组有40%的缺陷。在研究2中(最终体重:8.7+0.8公斤),可以给体重相似的婴儿开200,000IU的处方,31%的仔猪为维生素过多症,25,000IU组是100%VA充足,安慰剂组100%缺乏。MRDR测试在每项研究中测量了安慰剂组的50%和70%的缺乏,但在研究1中的维生素过多症仔猪中有三个假阳性。
结论:反复高剂量VA可能会导致维生素过多症,指示剂量大小可能需要减少。MRDR在营养不良期间导致高维生素血症状态的假阳性,应与血清视黄醇酯评估配对,以增强重叠干预措施人群的VA状态评估。
BACKGROUND: Vitamin A (VA) deficiency and excess negatively affect development, growth, and bone health. The World Health Organization\'s standard of care for
xerophthalmia due to VA deficiency, is 3 high-dose VA supplements of 50,000-200,000 IU, based on age, which may cause hypervitaminosis A in some individuals.
OBJECTIVE: This study measured VA status following 3 VA doses in 2 piglet studies.
METHODS: In Study 1, 5 groups of piglets (n = 10/group) were weaned 10 d postbirth to VA-free feed and orally administered 0; 25,000; 50,000; 100,000; or 200,000 IU VA ester on days 0, 1, and 7. On days 14 and 15, the piglets underwent the modified relative dose-response (MRDR) test for VA deficiency, and were killed. Tissues were collected for high-pressure liquid chromatography analysis. Study 2 used the same design in 3 groups (n = 13/group) weaned at 16 d and administered 0; 25,000; and 200,000 IU doses.
RESULTS: In Study 1 (final weight: 3.6 ± 0.7 kg), liver VA concentration was hypervitaminotic in 40%, 90%, and 100% of 50,000; 100,000; and 200,000 IU groups, respectively. The 25,000 IU group was 100% adequate, and the placebo group was 40% deficient. In Study 2 (final weight: 8.7 ± 0.8 kg), where 200,000 IU could be prescribed to infants with a similar body weight, 31% of the piglets were hypervitaminotic, the 25,000 IU group was 100% VA adequate, and the placebo group was 100% deficient. The MRDR test measured deficiency in 50% and 70% of the placebo group in each study but had 3 false positives among hypervitaminotic piglets in Study 1.
CONCLUSIONS: Repeated high-dose VA may cause hypervitaminosis, indicating dose sizes may need reduction. The MRDR resulted in false positives in a hypervitaminotic state during malnutrition and should be paired with serum retinyl ester evaluation to enhance VA status assessment in populations with overlapping interventions.